Antonia B.
- Country
- Germany
- Department
- Klinik für Hämatologie und Onkologie, Comprehensive Cancer Center (CCC)
Research Overview
- A Phase I Study of TK-6302 in Patients with Advanced PRAME-Positive Solid Tumors Harboring the HLA-A*02:01 Allele
- A Phase I Multicenter Study of Autologous CD19 CAR T-Cell Therapy in Patients with Refractory Chronic Graft-versus-Host Disease
- CAPTOR-BC: COMPREHENSIVE ANALYSIS OF SPATIAL, TEMPORAL AND MOLECULAR PATTERNS OF RIBOCICLIB EFFICACY AND RESISTANCE IN ADVANCED BREAST CANCER PATIENTS
Data & Insights
Has run more than one trial at 50 of 223 partner sites.
Specializations
Oncology & Immunotherapy
This investigator specializes in advanced therapeutic approaches for solid tumors, with particular emphasis on cell-based immunotherapy and CAR-T cell treatments. Their research extends to novel combinations of cellular therapies with RNA-based vaccines.
- Solid Tumor Treatment Innovation
- Cell Therapy Development
- Immunological Response Studies
Breast Cancer Research
The investigator focuses on treating various forms of breast cancer, including HER2-negative, hormone receptor-positive, and triple-negative breast cancer. Their work encompasses innovative approaches to metastatic breast cancer treatment and therapy optimization.
- Advanced Breast Cancer Therapeutics
- Targeted Therapy Applications
- Treatment Response Assessment
Advanced Cancer Treatment
Their expertise extends to treating melanoma, non-small cell lung cancer, and various other advanced malignancies. The investigator specializes in combination therapy approaches and the development of personalized treatment strategies for metastatic diseases.
- Novel Drug Combinations
- Targeted Molecular Therapies
- Treatment Resistance Studies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.